Children and Young Adults Who Used Medication for Attention Deficit Hyperactivity Disorder Faced Increased Cardiac Risks
Acta Paediatrica · 2025
DOI: 10.1111/apa.70215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Paediatrica, 2025. Verfasst von Howaida Elmowafi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Central Nervous System Stimulants, Heart Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Swedish Research Council for Health, Working Life and Welfare, The Swedish Heart and Lung Association, FORTE.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Aim
There have been concerns about links between medication for attention deficit hyperactivity disorder (ADHD) and cardiac events in children and young people. Our aim was to identify any associations.
Method
This Swedish case–control study used national register data to identify individuals aged 5–30 years who received their first diagnosis of a cardiac arrest, arrhythmia, fainting or collapse in 2006–2018. Each case was matched with five controls, by age, sex and region. Associations between ADHD medication and cardiac events were assessed using adjusted odds ratios (aORs) with 95% confidence intervals (CIs). Adjustments were made for concomitant medications and comorbidities, including congenital heart disease (CHD).
Results
We studied 112 605 cases (57.9% female), with a median age of 20 years (range 5–30), and 563 024 matched controls. Using ADHD medication was associated with cardiac events (aOR 1.63, 95% CI 1.47–1.81) across sexes and age groups. Undefined arrhythmias had the strongest association (aOR 2.66, 95% CI 2.27–3.13). Cardiac arrests and defined arrhythmias had no associations. Long‐term medication was associated with an increased risk (aOR 1.20, 95% CI 1.12–1.28). CHD had no impact.
Conclusion
ADHD medication was associated with cardiac events, particularly undefined arrhythmias. CHD did not increase the risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden.
- Department of Drug Treatment, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
- Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
- Department of Clinical Sciences, Child and Adolescent Psychiatry, Umeå University, Umeå, Sweden.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
- Department of Adolescent Psychiatry, Helsinki University Hospital, Helsinki, Finland.
ORCID-Profile: Howaida Elmowafi, Jenny M Kindblom, Linda Halldner
Förderung
- The Swedish Research Council for Health, Working Life and Welfare
- The Swedish Heart and Lung Association
- FORTE
- Forskningsrådet om Hälsa, Arbetsliv och Välfärd
Zitieren
APA
Elmowafi, H., Kindblom, J. M., Halldner, L., Gyllenberg, D., & Naumburg, E. (2025). Children and Young Adults Who Used Medication for Attention Deficit Hyperactivity Disorder Faced Increased Cardiac Risks. Acta Paediatrica. https://doi.org/10.1111/apa.70215
Vancouver
Elmowafi H, Kindblom JM, Halldner L, Gyllenberg D, Naumburg E. Children and Young Adults Who Used Medication for Attention Deficit Hyperactivity Disorder Faced Increased Cardiac Risks. Acta Paediatrica. 2025. doi:10.1111/apa.70215
BibTeX
@article{Elmowafi2025,
author = {Elmowafi, Howaida and Kindblom, Jenny M and Halldner, Linda and Gyllenberg, David and Naumburg, Estelle},
title = {Children and Young Adults Who Used Medication for Attention Deficit Hyperactivity Disorder Faced Increased Cardiac Risks},
journal = {Acta Paediatrica},
year = {2025},
doi = {10.1111/apa.70215}
}
EUVIMED